These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1752152)

  • 21. Postprandial gallbladder motility during long term treatment with the long-acting somatostatin analog SMS 201-995 in acromegaly.
    van Liessum PA; Hopman WP; Pieters GF; Jansen JB; Smals AG; Rosenbusch G; Kloppenborg PW; Lamers CB
    J Clin Endocrinol Metab; 1989 Sep; 69(3):557-62. PubMed ID: 2760170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [An observation of the secretion of growth hormone and contraction of gall bladder after long-term use of growth-inhibition excitants].
    Zhu XF; Shi YF; Gao SM
    Zhonghua Nei Ke Za Zhi; 1994 Feb; 33(2):87-91. PubMed ID: 8070297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR.
    Moschetta A; Stolk MF; Rehfeld JF; Portincasa P; Slee PH; Koppeschaar HP; Van Erpecum KJ; Vanberge-Henegouwen GP
    Aliment Pharmacol Ther; 2001 Feb; 15(2):181-5. PubMed ID: 11148435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of octreotide on biliary lipid composition and occurrence of cholesterol crystals in patients with acromegaly. A prospective study.
    Erlinger S; Chanson P; Dumont M; Ponsot P; Warnet A; Harris AG
    Dig Dis Sci; 1994 Nov; 39(11):2384-8. PubMed ID: 7956607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic exocrine and gallbladder function during long-term treatment with octreotide (SMS 201-995).
    Hopman WP; van Liessum PA; Pieters GF; Smals AG; Tangerman A; Jansen JB; Rosenbusch G; Lamers CB; Kloppenborg PW
    Digestion; 1990; 45 Suppl 1():72-6. PubMed ID: 2185969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of octreotide on gall stone prevalence and gall bladder motility in acromegaly.
    Catnach SM; Anderson JV; Fairclough PD; Trembath RC; Wilson PA; Parker E; Besser GM; Wass JA
    Gut; 1993 Feb; 34(2):270-3. PubMed ID: 8432484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in glucose tolerance and development of gall stones during high dose treatment with octreotide for acromegaly.
    McKnight JA; McCance DR; Crothers JG; Atkinson AB
    BMJ; 1989 Sep; 299(6699):604-5. PubMed ID: 2508821
    [No Abstract]   [Full Text] [Related]  

  • 28. Gallstones during octreotide therapy.
    Dowling RH; Hussaini SH; Murphy GM; Wass JA
    Digestion; 1993; 54 Suppl 1():107-20. PubMed ID: 8103009
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group.
    Vance ML; Harris AG
    Arch Intern Med; 1991 Aug; 151(8):1573-8. PubMed ID: 1872661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current alternative in the pharmacotherapy of acromegaly: the long-acting somatostatin analogue octreotide].
    Laczi F; Magony S; Julesz J
    Orv Hetil; 2002 May; 143(19 Suppl):1062-6. PubMed ID: 12063861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.
    Quabbe HJ; Plöckinger U
    J Clin Endocrinol Metab; 1989 May; 68(5):873-81. PubMed ID: 2565912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of acromegaly with octreotide: effectiveness and tolerability of its pulsatile administration by portable pump.
    Giusti M; Cuttica CM; Cariola G; Valenti S; Sessarego P; Giordano G
    Recenti Prog Med; 1995 May; 86(5):189-94. PubMed ID: 7604174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proceedings of the workshop, "Practical approaches to the diagnosis and treatment of acromegaly".
    Liuzzi A; Sobrinho LG; Besser GM
    Metabolism; 1992 Sep; 41(9 Suppl 2):87-90. PubMed ID: 1518440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long term effects of continuous subcutaneous infusion of the somatostatin analog octreotide in the treatment of acromegaly.
    Tauber JP; Babin T; Tauber MT; Vigoni F; Bonafe A; Ducasse M; Harris AG; Bayard F
    J Clin Endocrinol Metab; 1989 May; 68(5):917-24. PubMed ID: 2565913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors.
    Trendle MC; Moertel CG; Kvols LK
    Cancer; 1997 Feb; 79(4):830-4. PubMed ID: 9024721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lincomycin-induced cholecystitis and gallstones in guinea pigs.
    Scott AJ
    Gastroenterology; 1976 Nov; 71(5):814-20. PubMed ID: 964573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-term treatment with octreotide of patients with acromegaly].
    Weeke J; Orskov H; Christensen SE; Kaal A; Skjaerbaek C; Illum P; Jørgensen J; Lund E; Haubek A; Poulsen JH
    Ugeskr Laeger; 1993 Aug; 155(34):2592-8. PubMed ID: 8212364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of long term octreotide on gall stone formation and gall bladder function.
    Bigg-Wither GW; Ho KK; Grunstein RR; Sullivan CE; Doust BD
    BMJ; 1992 Jun; 304(6842):1611-2. PubMed ID: 1628089
    [No Abstract]   [Full Text] [Related]  

  • 39. A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients.
    van der Hoek J; de Herder WW; Feelders RA; van der Lely AJ; Uitterlinden P; Boerlin V; Bruns C; Poon KW; Lewis I; Weckbecker G; Krahnke T; Hofland LJ; Lamberts SW
    J Clin Endocrinol Metab; 2004 Feb; 89(2):638-45. PubMed ID: 14764775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term treatment of acromegaly with the somatostatin analog octreotide (Sandostatin). On the predictive significance of acute tests].
    Schmidt K; Althoff PH; Harris A; Hofmeister-Wagner W; Schifferdecker E; Schöffling K
    Med Klin (Munich); 1990 Dec; 85(12):700-6. PubMed ID: 2128367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.